KALA BIO, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
KALA BIO, INC. (KALA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $7.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-04-15
- KALA BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $7.36M, a 31.74% decline from fiscal 2024.
- KALA BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $10.78M, a 47.11% increase from fiscal 2023.
- KALA BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $7.33M.
- KALA BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$2.73M, a 107.46% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $7.36M 10-K · filed 2026-04-15 |
| 2024-12-31 | $10.78M 10-K · filed 2026-04-15 |
| 2023-12-31 | $7.33M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$2.73M 10-K · filed 2024-03-29 |
| 2021-12-31 | $36.57M 10-K · filed 2023-03-03 |
| 2020-12-31 | $17.49M 10-K · filed 2022-03-29 |
| 2019-12-31 | $13.50M 10-K · filed 2020-02-12 |
| 2018-12-31 | $16.40M 10-K · filed 2019-03-12 |
| 2017-12-31 | -$900.00K 10-K · filed 2019-03-12 |
| 2016-12-31 | $14.60M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |